Search results for: 'dure access control'

The global biopharma patient access market is undergoing a structural shift as specialty medicines make downstream commercialization more complex and strategically important. Patient access is no longer limited to reimbursement support or hub services; it is becoming a commercialization control layer spanning authorization, affordability, therapy i...

This study covers U.S. markets for venous access devices including peripherally inserted central catheters (PICCs), central venous catheters (CVCs), dialysis catheters, implantable ports, and catheter securement devices. This combination of new technology and expanding patient population will drive venous access catheters into significant growth th...

The widespread outbreak of COVID-19 across the world has overburdened hospitals with a huge influx of patients. Traditional hospitals that rely on manual and analog methods have been unable to handle the huge patient load with limited resources and this has severely impacted the ability of hospitals to provide quality care to patients. To address t...

30 Apr 2020  |  Asia Pacific  |  Market Outlook

COVID-19—Implications for the Healthcare Industry, 2020

Winning Strategies and Key Opportunities that are Evolving During this Disruption

Infographics

×

A team of futurists, analysts, and consultants from the Global Transformational Health Research Team at Frost & Sullivan have come together to render a comprehensive analysis to predict the future of healthcare with COVID-19 disruption in perspective. This study provides actionable predictions and growth opportunities for major healthcare segments ...

Scope of the report The research report includes the following segments: Product scope: Pharmaceutical Products Geographic scope: Ethiopia End-user scope: Pharmaceutical manufacturers, Pharmaceutical distributors, Healthcare providers, Contract Manufacturing Organisations (CMO) Revenue analysis and forecasts, drivers and restraints, business opp...

The rise in both global population and travel is contributing to the increase in spread of infectious diseases. Rapid and accurate identification of the infectious pathogens are imperative for timely intervention, better patient outcomes, and control and management of the spread of the infection. Conventional infectious disease diagnoses are perfor...

The research service aims to analyse and assess the Therapeutic Monoclonal Antibodies market in Europe. This is performed by analysing the key trends and dynamics shaping the industry sector in correlation with the market drivers and restraints. With several key blockbuster drugs losing patent protection and an immense rise in the rate of disease i...

Research shows that environmental surfaces in healthcare settings play a crucial role in pathogen transmission, leading to healthcare-acquired infections (HAIs), which have a considerable cost burden. Outpatient settings also pose significant infection risks. In the United States, millions of patients frequent outpatient facilities such as ambulato...

The cardiac monitoring market will benefit from healthcare delivery challenges by promoting advanced monitoring solutions that help providers reduce 30-day readmissions for cardiac-associated conditions. Interest in the remote patient monitoring space is altering portfolio approaches across products and services. Changes in payments, particularly g...